<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Absence of telomerase reverse transcriptase promoter mutations in neuroblastoma</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>Dr</roleName><forename type="first">Sven</forename><surname>Lindner</surname></persName>
							<email>sven.lindner@rub.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Pediatric Oncology and Hematology</orgName>
								<orgName type="institution">University Children&apos;s Hospital Essen</orgName>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">German Cancer Research Center (DKFZ)</orgName>
								<address>
									<postCode>D-69120</postCode>
									<settlement>Heidelberg</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Hagen</forename><forename type="middle">S</forename><surname>Bachmann</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Institute of Pharmacogenetics</orgName>
								<orgName type="institution">University Hospital Essen</orgName>
								<address>
									<postCode>D-45147</postCode>
									<settlement>Essen</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andrea</forename><surname>Odersky</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Pediatric Oncology and Hematology</orgName>
								<orgName type="institution">University Children&apos;s Hospital Essen</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Simon</forename><surname>Schaefers</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Pediatric Oncology and Hematology</orgName>
								<orgName type="institution">University Children&apos;s Hospital Essen</orgName>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">German Cancer Research Center (DKFZ)</orgName>
								<address>
									<postCode>D-69120</postCode>
									<settlement>Heidelberg</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ludger</forename><surname>Klein-Hitpass</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Institute of Cell Biology (Cancer Research)</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine</orgName>
								<orgName type="institution">University of Duisburg-Essen</orgName>
								<address>
									<postCode>D-45122</postCode>
									<settlement>Essen</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Barbara</forename><surname>Hero</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Department of Pediatric Oncology and Hematology</orgName>
								<orgName type="institution">University Children&apos;s Hospital of Cologne</orgName>
								<address>
									<postCode>D-50924</postCode>
									<settlement>Cologne</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Matthias</forename><surname>Fischer</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Department of Pediatric Oncology and Hematology</orgName>
								<orgName type="institution">University Children&apos;s Hospital of Cologne</orgName>
								<address>
									<postCode>D-50924</postCode>
									<settlement>Cologne</settlement>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="department">Center for Molecular Medicine Cologne (CMMC)</orgName>
								<orgName type="institution">University of Cologne</orgName>
								<address>
									<postCode>D-50931</postCode>
									<settlement>Cologne</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Angelika</forename><surname>Eggert</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Department of Pediatric Oncology/Hematology</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<postCode>D-10117</postCode>
									<settlement>Berlin</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Alexander</forename><surname>Schramm</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Pediatric Oncology and Hematology</orgName>
								<orgName type="institution">University Children&apos;s Hospital Essen</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Johannes</forename><forename type="middle">H</forename><surname>Schulte</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Pediatric Oncology and Hematology</orgName>
								<orgName type="institution">University Children&apos;s Hospital Essen</orgName>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">German Cancer Research Center (DKFZ)</orgName>
								<address>
									<postCode>D-69120</postCode>
									<settlement>Heidelberg</settlement>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="department" key="dep1">Translational Neuro-Oncology</orgName>
								<orgName type="department" key="dep2">West German Cancer Center (WTZ)</orgName>
								<orgName type="institution">University Hospital Essen</orgName>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="department">Centre for Medical Biotechnology</orgName>
								<address>
									<addrLine>University Duisburg-Essen</addrLine>
									<postCode>D-45147</postCode>
									<settlement>Essen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="institution">German Consortium for Translational Cancer Research (DKTK)</orgName>
								<address>
									<addrLine>Partner Site Essen/Duesseldorf</addrLine>
									<postCode>D-45122</postCode>
									<settlement>Essen</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff10">
								<orgName type="department">Department of Pediatric Oncology and Haematology</orgName>
								<orgName type="institution">University Children&apos;s Hospital Essen</orgName>
								<address>
									<addrLine>Hufelandstrasse 55</addrLine>
									<postCode>D-45122</postCode>
									<settlement>Essen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Absence of telomerase reverse transcriptase promoter mutations in neuroblastoma</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">0503660253973A63DE54CCEF99CD17DC</idno>
					<idno type="DOI">10.3892/br.2015.463</idno>
					<note type="submission">Received March 13, 2015; Accepted April 22, 2015</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:13+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>neuroblastoma</term>
					<term>telomerase reverse transcriptase</term>
					<term>alternative lengthening of telomeres</term>
					<term>telomeres</term>
					<term>sequencing</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Maintenance of telomere length is a critical hallmark of malignant transformation.</s><s>While silenced in somatic cells, telomerase reverse transcriptase (TERT), the catalytic subunit of telomerase, is frequently overexpressed in malignant cells thereby maintaining their telomere length.</s><s>Specific point mutations in the TERT promoter region have recently been identified in melanoma and other tumor entities resulting in high TERT expression.</s><s>Neuroblastoma is the most common extracranial tumor of childhood, arising from neural-crest progenitor cells.</s><s>TERT overexpression has been observed in the majority of neuroblastoma.</s><s>Taking into consideration that TERT promoter mutations are frequently described in neural-crest-derived tumors such as melanoma, as well as a variety of other neuronal tumors, the present study analyzed the frequency of TERT promoter mutations in primary neuroblastoma and neuroblastoma cell lines.</s><s>In 131 neuroblastoma primary tumors representing the whole spectrum of neuroblastoma, no TERT promoter mutations were detected.</s><s>However, in 3 out of 19 neuroblastoma cell lines the previously described C228T TERT promoter mutation was present.</s><s>In conclusion, the TERT promoter mutations are not a frequent mechanism of TERT overexpression in neuroblastoma.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Each mitotic cell division results in the shortening of telomeres <ref type="bibr" target="#b0">(1)</ref>.</s><s>In somatic cells, subsequent shortening of telomeres eventually leads to senescence.</s><s>The multiunit enzyme telomerase maintains telomere length by adding repetitive sequences to telomeres at each replicative cycle.</s><s>However, the telomerase activity is absent in somatic cells.</s><s>By contrast, malignant cells (re-)express telomerase or use an alternative mechanism to maintain telomere length, known as alternative lengthening of telomeres (ALT) <ref type="bibr" target="#b1">(2)</ref>.</s></p><p><s>Telomerase reverse transcriptase (TERT) is an essential part of the telomerase enzyme complex <ref type="bibr" target="#b2">(3)</ref>.</s><s>Most recently, specific point mutations were described in the promoter region of the TERT gene in familial and sporadic melanoma <ref type="bibr" target="#b3">(4)</ref>.</s><s>These point mutations lead to a cytosine to thymine exchange at the positions 228 or 250 upstream of the start codon of TERT, further referred to as C228T and C250T, respectively <ref type="bibr" target="#b2">(3)</ref><ref type="bibr" target="#b3">(4)</ref><ref type="bibr" target="#b4">(5)</ref>.</s><s>Through these mutations, the TERT promoter acquires novel binding sites for the E twenty-six transcription factor, resulting in increased TERT expression <ref type="bibr" target="#b5">(6)</ref>.</s><s>Subsequently, TERT promoter mutations were described in a variety of tumors, including several neuronal tumors as medulloblastoma <ref type="bibr" target="#b6">(7)</ref> and glioma, as well as other tumor entities <ref type="bibr" target="#b3">(4,</ref><ref type="bibr" target="#b4">5)</ref>.</s><s>Of note, the presence of TERT promoter mutations often correlated with aggressive disease and an adverse outcome.</s></p><p><s>Neuroblastoma is the most common extracranial tumor during childhood arising from the neural-crest <ref type="bibr" target="#b7">(8,</ref><ref type="bibr" target="#b8">9)</ref>.</s><s>Only few recurrent mutations or genomic rearrangements have been described thus far <ref type="bibr" target="#b9">(10)</ref>.</s><s>Among these are the genomic amplifications of MYCN and activating mutations of anaplastic lymphoma kinase.</s><s>Most recently, two independent studies described ALT through mutations in the transcriptional regulator α-thalassemia/mental retardation X-linked (ATRX) in a minor fraction of neuroblastomas <ref type="bibr" target="#b10">(11,</ref><ref type="bibr" target="#b11">12)</ref>.</s><s>Although the ALT phenotype may not be limited to neuroblastomas with ATRX mutations, the majority of neuroblastomas express telomerase and in particular TERT <ref type="bibr" target="#b13">(13)</ref>.</s><s>Of note, high TERT expression was detected in MYCN-amplified tumors, but even in MYCN single copy neuroblastomas a high TERT expression correlated with adverse outcome <ref type="bibr" target="#b13">(13)</ref>.</s><s>By contrast, low or absent TERT expression was detected in favorable neuroblastomas and absence of telomerase activity has been proposed as a potential mechanism to explain the high rate of spontaneous regression of favorable neuroblastomas <ref type="bibr" target="#b14">(14)</ref>.</s><s>While MYCN is known to induce TERT transcription <ref type="bibr" target="#b15">(15,</ref><ref type="bibr" target="#b16">16)</ref> and TERT amplification has been described in few neuroblastoma cases <ref type="bibr" target="#b17">(17)</ref>, the mechanism that drives TERT expression remains elusive in the majority of neuroblastomas.</s></p><p><s>As TERT promoter mutations a re frequent in neural-crest-derived melanoma, as well as in various neuronal tumors including medulloblastoma, the present study analyzed the frequency of TERT promoter mutations in neuroblastoma.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and methods</head><p><s>Primary tumor samples.</s><s>Primary tumor samples and patient data were obtained from the German Society of Pediatric Oncology and Hematology Tumor Bank and Neuroblastoma Study Center (Cologne, Germany), respectively.</s><s>All the patients were registered with the German neuroblastoma study and written informed consent was obtained.</s><s>A tumor content of ≥60% was confirmed by a pathologist.</s><s>DNA was isolated from ~20 mg of snap-frozen tissue obtained prior to cytotoxic treatment using the Puregene Blood Core kit B (Qiagen, Hilden, Germany), according to the manufacturer's instructions.</s></p><p><s>Cell culture.</s><s>Neuroblastoma cell lines BEC(2), CHP134, IMR-32, IMR-5-75, KCN, KCN(R), Kelly, LAN1, LAN5, LAN6, NGP, NLF, SH-EP, SH-SY5Y, SK-N-AS, SK-N-BE, SK-N-FI and SK-N-SH were cultured in RPMI-1640 supplemented with 10% fetal calf serum, 5% penicillin (100 U/ml) and streptomycin (100 µg/ml) until reaching a confluence of 70%.</s><s>Cells were collected and DNA was isolated using the QIAamp DNA kit (Qiagen).</s><s>All the cell lines were authenticated by short tandem repeat genotyping performed by DSMZ (Braunschweig, Germany) or IDEXX GmbH (Ludwigsburg, Germany).</s></p><p><s>Polymerase chain reaction (PCR) and sequencing.</s><s>DNA (100 ng) was used for the PCR reaction.</s><s>To each PCR reaction, TERT forward (ACGAACGTGGCCAGCGGCAG) and reverse primers (CTGGCGTCCCTGCACCCTGG) were added to amplify a 474-base pair (bp) long region of the TERT promoter (390-bp upstream and 80-bp downstream of the start codon).</s><s>The PCR program used was as follows: 95˚C for 180 sec, followed by 95˚C for 30 sec, 62˚C for 45 sec and 72˚C for 60 sec repeated 35 times, and a final amplification step at 72˚C for 600 sec.</s><s>Sanger sequencing was performed by Sequence Laboratories Göttingen GmbH (Göttingen, Germany).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Reverse transcription-quantitative PCR (RT-qPCR).</head><p><s>Total RNA was isolated from cells using the RNeasyMini kit (Qiagen) and cDNA synthesis was performed using the SuperScript ® RT kit (Invitrogen Life Technologies, Darmstadt, Germany).</s><s>TERT expression was monitored using the QuantiTect Primer Assay™ (Qiagen).</s><s>Expression values were normalized to the geometric mean of GAPDH <ref type="bibr" target="#b18">(18)</ref>.</s><s>Data analysis and error propagation were performed using the qbasePLUS software version 1.5 (http://www.biogazelle.</s><s>com).</s></p><p><s>Pyrosequencing.</s><s>To determine the presence of the mutant C228T allele or the wild-type allele using pyrosequencing, the following primers were used to amplify a 151-bp amplicon: Biotinylated forward primer 5'-BIOTIN-CTTCACCTTCCA GCTCCGC-3', and reverse primer 5'-CGCTGCCTGAAA CTCGC-3'.</s><s>The PCR products were analyzed by pyrosequencing using the primer 5'-GAGGGGCTGGGAGGG CCC-3', on the PyroMark Q96 MD system according to the manufacturer's instructions (Qiagen) and as previously described <ref type="bibr" target="#b19">(19)</ref>.</s><s>Results were analyzed using PyroMark MD 1.0 software (Biotage, Uppsala, Sweden).</s></p><p><s>Genome-wide single-nucleotide polymorphism (SNP) analysis.</s><s>SNP array experiments were performed according to the standard protocol for Affymetrix CytoScanHD arrays (Affymetrix, Inc., Santa Clara, CA, USA).</s><s>In brief, a 250-ng sample of genomic DNA was digested with NspI, ligated to adaptors, amplified by PCR, fragmented and biotin-labeled.</s><s>The labeled samples were hybridized to Affymetrix CytoscanHD arrays, followed by washing, staining and scanning in the Affymetrix GeneChip Scanner 3000.</s><s>Analysis was performed using the Affymetrix Chromosome Analysis Suite v2.1.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>TERT promoter mutations are absent in primary neuroblastomas.</s><s>To determine the frequency of TERT promoter mutations in neuroblastoma, including the previously described C228T and C250T mutations, the respective TERT promoter region of 131 primary neuroblastomas was sequenced.</s><s>These tumors represented the whole spectrum of neuroblastoma regarding stage, MYCN and 1p36 status (Table <ref type="table" target="#tab_0">I</ref>).</s><s>Of note, none of the analyzed neuroblastomas harbored a C228T or a C250T mutation in the TERT promoter region.</s></p><p><s>TERT promoter mutations in neuroblastoma cell lines.</s><s>In addition to primary neuroblastomas, 19 neuroblastoma cell lines were analyzed.</s><s>In 3 out of 19 analyzed cell lines (16%) a mutation of the TERT promoter was detected.</s><s>The neuroblastoma cell lines SK-N-SH, SH-SY5Y and SH-EP harbor the C228T mutation (Fig. <ref type="figure" target="#fig_1">1A-C</ref>).</s><s>Of note, SH-SY5Y and SH-EP are subclones of SK-N-SH <ref type="bibr" target="#b20">(20)</ref>.</s><s>SK-N-SH was established from a bone marrow biopsy of a 4-year-old girl <ref type="bibr" target="#b21">(21,</ref><ref type="bibr" target="#b22">22)</ref>.</s><s>The presence of the C228T TERT promoter mutation in SK-N-SH, SH-SY5Y and SH-EP was independently validated using pyrosequencing (Fig. <ref type="figure" target="#fig_1">1B</ref>).</s><s>As the C228T mutation appeared to be homozygous in SK-N-SH, SH-SY5Y and SH-EP, Affymetrix Human SNP array 6.0 arrays were used to analyze zygosity.</s><s>The 3 probes located within the TERT gene were homozygeous in all three cell lines, which could point to the presence of a small loss-of-heterozygosity region spanning the TERT gene (Table <ref type="table" target="#tab_0">II</ref>).</s><s>To analyze if the mutations in the TERT promoter correlate with increased TERT expression, the expression was analyzed in all the neuroblastoma cell lines using RT-qPCR.</s><s>No correlation between mutations and TERT expression was detected (Fig. <ref type="figure" target="#fig_1">1D</ref>).</s></p><p><s>Table <ref type="table" target="#tab_0">II</ref>.</s><s>Location of the Affymetrix CytoScanHD array probes located within or near the TERT gene.</s><s>The probes lying within the TERT gene showed a loss of heterozygousity for SH-EP, SH-SY5Y and SK-N-SH.</s><s>Probes lying outside of the TERT gene showed a heterozygous status.</s></p><p><s>Zygosity status - <ref type="figure">----------------------------------------------------------------------------------------------------------</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>A B C D Discussion</head><p><s>Analysis of the TERT gene promotor region in 20 neuroblastoma cell lines and 131 primary neuroblastoma tumors revealed mutations in 3 cell lines and no mutations in primary tumors.</s><s>Of note, the only 3 mutated cell lines, which harbor the C228T mutation, are SK-N-SH and its 2 subclones SH-EP and SH-SY5Y, further limiting the general indication of this finding.</s><s>It is uncommon that TERT mutations occur homozygously, as detected in SK-N-SH, SH-EP and SY5Y.</s><s>However, further analysis confirmed a loss-of-heterozygosity region in the region of the TERT gene, pointing to a hemizygous rather than a homozygous status of the C228T mutation in these cases.</s><s>Taking into consideration the variable levels of TERT expression in SK-N-SH, SH-EP and SH-SY5Y cells, the functional indication of the C228T mutations in these cell lines remain questionable.</s></p><p><s>The absence of TERT mutations in primary neuroblastomas and the majority of analyzed cell lines is unexpected, as TERT expression is of pathogenic relevance in the majority of neuroblastomas <ref type="bibr" target="#b13">(13)</ref> and TERT mutations are frequent in related neuroectodermal tumors, such as melanoma and medulloblastoma <ref type="bibr" target="#b3">(4,</ref><ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b23">23,</ref><ref type="bibr" target="#b24">24)</ref>.</s><s>However, the present results are in line with previous studies by Papathomas et al <ref type="bibr" target="#b25">(25)</ref>, who did not find TERT promoter mutations in 15 primary neuroblastomas and Killela et al <ref type="bibr" target="#b23">(23)</ref>, who identified only 2 TERT promoter mutations in 22 neuroblastomas.</s></p><p><s>The mechanisms by which TERT expression is induced, particularly in MYCN non-amplified high-risk neuroblastomas, remains elusive and warrants further studies.</s><s>Potential alternative mechanisms underlying TERT induction in neuroblastoma include epigenetic changes, as well as mutations in more distant regulatory elements that were not analyzed in the present study.</s></p><p><s>Taken together, we conclude that TERT (core) promoter mutations are not relevant events in neuroblastoma pathogenesis.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>TERT gene Chromosomal position of TERT: Chr.5.1253167-1295047;</s><s>Chromosomal position of the C228T mutation: Chr.5.1295228.</s><s>TERT, telomerase reverse transcriptase.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>(A) Electropherogram examples of the cell lines SH-SY5Y, SH-EP and SK-N-SH harboring the C228T nucleotide exchange.</s><s>By contrast, LAN5 shows the wild-type (WT) sequence at the mutation hotspots.</s><s>(B) Representative pyrograms obtained for WT LAN5 cells, as well as SK-N-SH, SH-EP and SH-SY5Y cells, harboring the C228T telomerase reverse transcriptase (TERT) promoter mutation.</s><s>Pyrograms were generated by sequential addition of the single-nucleotide polymorphism-specific nucleotides shown beneath each trace.</s><s>Note that each peak corresponds to one or more identical bases added to the synthesized DNA-strand and that the height of each peak is correlated to the number of sequential nucleotides of the same type.</s><s>(C) List of the neuroblastoma cell lines sequenced for TERT promoter mutations (C228T=guanine to adenine nucleotide exchange upstream of the TERT promoter at position-228).</s><s>(D) TERT expression scaled to the lowest expression found in SK-N-SH (TERT expression=1).</s><s>The cell lines that carry a TERT promoter mutation are marked with 'mutated'.</s></p></div></figDesc><graphic coords="3,42.52,266.20,510.24,159.13" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table I .</head><label>I</label><figDesc><div><p><s>Patient data of the 131 sequenced primary neuroblastomas tumors.</s></p></div></figDesc><table><row><cell>Characteristics</cell><cell>Values, n</cell></row><row><cell>Patients</cell><cell>131</cell></row><row><cell>Gender</cell><cell></cell></row><row><cell>Female</cell><cell>47</cell></row><row><cell>Male</cell><cell>84</cell></row><row><cell>Stage (INSS)</cell><cell></cell></row><row><cell>1</cell><cell>29</cell></row><row><cell>2a</cell><cell>12</cell></row><row><cell>2b</cell><cell>7</cell></row><row><cell>3</cell><cell>19</cell></row><row><cell>4</cell><cell>50</cell></row><row><cell>4S</cell><cell>14</cell></row><row><cell>MYCN status</cell><cell></cell></row><row><cell>Non-amplified</cell><cell>96</cell></row><row><cell>Amplified</cell><cell>33</cell></row><row><cell>Not detectable</cell><cell>2</cell></row><row><cell>1p36 status</cell><cell></cell></row><row><cell>Wild-type</cell><cell>90</cell></row><row><cell>Deletion</cell><cell>24</cell></row><row><cell>Imbalance</cell><cell>12</cell></row><row><cell>Not detectable</cell><cell>5</cell></row><row><cell>Age at diagnosis, years</cell><cell></cell></row><row><cell>&lt;1</cell><cell>36</cell></row><row><cell>1-2</cell><cell>50</cell></row><row><cell>&gt;2</cell><cell>45</cell></row><row><cell>INSS, International Neuroblastoma Staging System.</cell><cell></cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>T he authors ack nowledge the f unding f rom the German Ministry for Education and Research (e:MED grant nos.</s><s>SMOOSE FKZ: 01ZX1303B and SYSMED-NB FKZ: 01ZX1307E to J.H.S.) and the German Cancer Aid (grant no.</s><s>111301 to J.H.S.).</s></p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Role of telomeres and telomerase in cancer</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Shay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">E</forename><surname>Wright</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Semin Cancer Biol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="349" to="353" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Alternative lengthening of telomeres pathway: Recombination-mediated telomere maintenance mechanism in human cells</title>
		<author>
			<persName><forename type="first">A</forename><surname>Nabetani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ishikawa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biochem</title>
		<imprint>
			<biblScope unit="volume">149</biblScope>
			<biblScope unit="page" from="5" to="14" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Griewank</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Murali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Schilling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Scholz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sucker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Süsskind</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Grabellus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zimmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Hillen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Cancer</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="page" from="497" to="501" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">TERT promoter mutations in familial and sporadic melanoma</title>
		<author>
			<persName><forename type="first">S</forename><surname>Horn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Figl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Rachakonda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sucker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gast</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kadel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Moll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Nagore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hemminki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">339</biblScope>
			<biblScope unit="page" from="959" to="961" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Highly recurrent TERT promoter mutations in human melanoma</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hodis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">V</forename><surname>Kryukov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Chin</forename><forename type="middle">L</forename><surname>Garraway</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">339</biblScope>
			<biblScope unit="page" from="957" to="959" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc</title>
		<author>
			<persName><forename type="first">D</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dwyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Duan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">283</biblScope>
			<biblScope unit="page" from="23567" to="23580" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma</title>
		<author>
			<persName><forename type="first">M</forename><surname>Remke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Ramaswamy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Peacock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Shih</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Koelsche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Northcott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Cavalli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kool</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neuropathol</title>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="page" from="917" to="929" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Targeted expression of MYCN causes neuroblastoma in transgenic mice</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Weiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Aldape</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Mohapatra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Feuerstein</forename><surname>Bg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Bishop</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EMBO J</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="2985" to="2995" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Maris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Hogarty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bagatell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Cohn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroblastoma. Lancet</title>
		<imprint>
			<biblScope unit="volume">369</biblScope>
			<biblScope unit="page" from="2106" to="2120" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">The genetic landscape of high-risk neuroblastoma</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Pugh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Morozova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">F</forename><surname>Attiyeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Asgharzadeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Auclair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Carter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Cibulskis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hanna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kiezun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="279" to="284" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Molenaar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Koster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Zwijnenburg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Van Sluis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Valentijn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Van Der Ploeg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hamdi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Van Nes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Westerman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Van Arkel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">483</biblScope>
			<biblScope unit="page" from="589" to="593" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Cheung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Parker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bahrami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Tickoo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Heguy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Pappo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Federico</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dalton</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">St Jude Children&apos;s Research Hospital-Washington University Pediatric Cancer Genome Project: Association of age at diagnosis and genetic mutations in patients with neuroblastoma</title>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">307</biblScope>
			<biblScope unit="page" from="1062" to="1071" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Telomerase activity and telomerase subunits gene expression patterns in neuroblastoma: A molecular and immunohistochemical study establishing prognostic tools for fresh-frozen and paraffin-embedded tissues</title>
		<author>
			<persName><forename type="first">C</forename><surname>Poremba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Scheel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Christiansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Schaefer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Nakayama</forename><surname>Ji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Berthold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Juergens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Boecker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Dockhorn-Dworniczak</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="2582" to="2592" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Mechanisms of neuroblastoma regression</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Brodeur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bagatell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="704" to="713" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Direct recruitment of N-myc to target gene promoters</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Mac</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>'cunha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Farnham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Carcinog</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="76" to="86" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">MYCN regulates oncogenic MicroRNAs in neuroblastoma</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Schulte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Horn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Otto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cancer</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="page" from="699" to="704" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Recurrent pre-existing and acquired DNA copy number alterations, including focal TERT gains, in neuroblastoma central nervous system metastases</title>
		<author>
			<persName><forename type="first">D</forename><surname>Cobrinik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Ostrovnaya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hassimi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Tickoo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">Y</forename><surname>Cheung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Cheung</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genes Chromosomes Cancer</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="1150" to="1166" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes</title>
		<author>
			<persName><forename type="first">J</forename><surname>Vandesompele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Preter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Pattyn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Biol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">H0034</biblScope>
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Regulatory BCL2 promoter polymorphism (-938C&gt;A) is associated with adverse outcome in patients with prostate carcinoma. International journal of cancer</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Bachmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Heukamp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Schmitz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cancer</title>
		<imprint>
			<biblScope unit="volume">129</biblScope>
			<biblScope unit="page" from="2390" to="2399" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Expression of neurotransmitter receptors and myc protooncogenes in subclones of a human neuroblastoma cell line</title>
		<author>
			<persName><forename type="first">W</forename><surname>Sadée</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">C</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Richards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">N</forename><surname>Preis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Schwab</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Brodsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Biedler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="5207" to="5212" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<monogr>
		<title level="m" type="main">The fine structure of continuous human neuroblastoma lines SK-N-SH, SK-N-BE(2) and SK-N-MC</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">N</forename><surname>Barnes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Biedler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Spengler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Lyser</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1981">1981</date>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="619" to="631" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Morphology and growth, tumorigenicity and cytogenetics of human neuroblastoma cells in continuous culture</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Biedler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Helson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Spengler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="2643" to="2652" />
			<date type="published" when="1973">1973</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Killela</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">J</forename><surname>Reitman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Jiao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bettegowda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Agrawal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Diaz</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Friedman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Friedman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Gallia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Giovanella</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="6021" to="6026" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">TERT promoter mutation and aberrant hypermethylation are associated with elevated expression in medulloblastoma and characterise the majority of non-infant SHH subgroup tumours</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Lindsey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Schwalbe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Potluri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bailey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Williamson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Clifford</forename><surname>Sc</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neuropathol</title>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="page" from="307" to="309" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paraganglia</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">G</forename><surname>Papathomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Oudijk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Zwarthoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Post</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">A</forename><surname>Duijkers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Van Noesel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Hof Land</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Pollard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Maher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Restuccia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocr Relat Cancer</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="653" to="661" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
